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Carcinoembryonic antigen (CEA) is one of the most widely used human t,umour 
markers, especially in the post-operative surveillance of patients with colonic 
tumours (1.2). A number of closely related molecules have been described which 
crossreact with CEA antisera, indicating a CEA-family. The exact size of the CEA 
family has been difficult to determine for a number of reasons which were recently 
discussed (3). However, protein sequencing (4.5). as well as DNA sequencing has 
lead to the identification of the complete primary structures of CEA (6,7,8), a non- 
specific crossreacting antigen (NCA: 9,10,11 ,12), biliary glycoprotein I. (BGPl : 13), 
pregnancy-specific BI-glycoprotein (PSBG-C/D, PSGIG, PSG93: 14,151, PSSG-E (14), 
and “Schwangerschaftsprotein 1” (SPI: 16). These molecules exhibit sequence 
similarities, and can be subdivided into several domains: a leader peptide. an 
N-terminal domain, a variable number of repeating units, and apart from BGPI, a 
short C-terminal domain. In the case of BGPl. a transmembrane region and a 
cytoplasmic domain follow the repeat domains. The deduced primary and secondary 
structures of all these CEA-related molecules reveal homology to the immunoglobu- 
lin superfamily (4,17,18). 
: CEA = carcinoembr onic 
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DNA/DNA hybridization studies indicate that approximately 10 genes exist in the 
CEA family (7,9,19). We have started to screen human genomic libraries in an 
attempt to isolate and identify all these genes. For this purpose, we have decided 
to concentrate our investigations on the N-terminal regions of the genes for two 
main reasons. Firstly, this domain appears to be present only once per antigen 
(31, whereas multiple copies of the repeat domain are known to exist in CEA 
(6,7,81, and in other genes belonging to this family (20). Secondly, in order to 
identify these genes with respect to their products, it is apparently easier to gain 
partial protein sequence data from the N-terminal domains than from other 
regions of CEA-like antigens (4,5). In this paper, we shall present sequence data 
from the N-terminal domains of five genes belonging to the CEA family. 
Materials and Methods 
Chemicals and oligonucleotides: T4 DNA 
fragment of DNA-polymerase I from 
li ase, polynucleotide kinase, the Klenow 
Escher chia coli, and restriction endonucleases P 
were from Boehringer Mannheim Biochemica, Bethesda Research Laboratories and 
Pharmacia/LKB. Low-zellinz temnerature aearose was obtained from International 
Biotechnologies Inc. - and- Sigma. Nitroc&ulose filters were purchased from 
Schleicher and Schuell. Radiochemicals were sup hlld b 
England Nuclear. The sequencin 
fi 
kits were from 8 &.atZY~~~~?ZrnZrZ IZZ 
Amersham. RNasin was obtaine from Amersham. All other chemicals were of 
analytical rade. 
on an App led Biosystems 308A DNA synthesizer, and f* 
Oligonucleotides were synthesized by the phos horamidite method 
manufacturers protocol. 
purifie 2 according to the 
Bacterial strains, human genomic library and cloning vectors: All work with 
Screenin 
oligonuc eotides (see Results), were radiolabelled (221, and f 
of the human genomic libraries: Various DNA fra ments 
% 
and two 
use to screen the 
human genomic libraries (23). Recombinant phages were amplified and transferred 
to nitrocellulose filters (24). Colony hybridization (23) was used to identify the 
cosmid clones. Hybridization with DNA fra ments was carried out overni ht at 44’C 
in 6x SSPE (lx SSPE = 0.18M NaCl, 1 mM NaH2PO4 pH 7.4, 1mM E TA), 8 8 0.6% 
(w/v) SDS, 5x Denhardt’s solution, 30% formamide, lOOpg/ml denatured calf thymus 
DNA, 1OmM EDTA and 1 x log dpm/ml [a-32Pl dATP- labelled DNA fragment. The 
filters were washed twice (lo-16 min at room tern erature) 
followed by two low stringency washes (lh each a ! 
in 2x SSPE, 0.5% SDS, 
66’C) in the same buffer. The 
were washed t ree times in 6x SSPE. 0.1% SD R 
robes were 5’-end-labelled and h 
B 
bridized as described (25). Filters 
(16 min at room temperature), 
oligonucleotide 
followed by 15 min washes up to high stringency (60-65’C in the same buffer). 
Positive plaques were isolated and plaque purified (23). 
Determination of DNA sequences: Subcloned restriction fragments in phage 
M13mp18/19 and Bluescript phagemid were sequenced as sin le or double stranded 
templates by the dideoxy-chain-termination method (261, f 
T3 T7 SK KS (Strata ene) 
us ng universal, reverse 
the nucleotide and de uced % 
or internal oligonucleotide primers. For comparison of 
amino acid sequences, the computer 
(M. Trippel, Freiburf and R. Friedrich, Giessen,. un ublished) 
pro ram 
% 
“Align” 
was use . Secondary 
P 
rotein structure ca culations were performed with P 
PCgene, Genofit, Switzerland). 
he computer program “Novotny 
RNA blot hybridization: Isolation and analysis of RNA by Northern blot hybridiza- 
tion was performed as described (271. 
Results 
For the first screening, a 534bp Pst I fragment from the repeat domains of the 
CEA cDNA clone pCEA1 (6) was used to probe a human genomic lambda library. 
After applying low stringency hybridization conditions, 78 clones were picked. For 
further analyses, a Pst I fragment from an NCA cDNA clone, pNCA1, which covers 
approximately the last two thirds of the leader and half of the N-terminal domain 
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1 Structure of subfragments of six genomic clones containing the N-terminal 
%i%& exons of CEA-related fenes. Leader (L) and N-terminal domains are 
depicted by hatched and stipp ed boxes, 
fragment whose se uence has been 
res ectively. 
9t 
publishe B 
The Pst I/Eco RI NCA 
reference. The V-un ranslated 
elsewhere (9) is included for 
region Is depleted as an o en box. The transcript- 
ional start which is assumed in analogy to primer extens on data for CEA (8) and P 
un 
B 
ubllshed data from us for NCA is indicated by a broken line. The smaller solid 
da?CT) 
horizontally-lined boxes symbolize simple repeated se uences 
units res ectively. 
sequencing ‘and P 
Restriction endonuclease sites re evant for subcloning ‘f 
of d(CA) and 
dentification of probes for Northern analyses are indicated. Thi 
sequencing strategy is shown by arrows. 
was used as a probe (unpublished results). Using the same low stringency condi- 
tions as for the first probe, 28 clones also hybridized with this DNA fragment. 
Three approaches were then adopted in an attempt to identify clones representing 
genes belonging to the CEA family which have so far not been analysed. Firstly, a 
direct isolation of the gene for CEA was attempted using a presumably CEA-speci- 
fit (CEA 3+) oligonucleotide. which has been described elsewhere (9). At a high 
stringency wash, one clone &hsCGMl-I), was identified which preferentially hybri- 
dized with this oligonucleotide. Sequence analyses revealed that it does not 
represent the CEA gene, but a closely related one (see Figures 1, 2 and 3). In a 
second approach, a lkb, Eco RI, DNA fragment from the intron between the 
N-terminal and first repeat exons of an NCA gene (9), was used as a probe. Of the 
28 clones which had hybridized with the repeat and N-terminal probes, 4 were 
identified which did not hybridize with this DNA fragment and could not, 
therefore, represent the NCA gene. Digestion of the recombinant phage DNAs with 
different restriction endonucleases and hybridization with the various probes des- 
cribed above, revealed that three of these clones were apparently from the same 
chromosomal locus (data not shown). One of these three AhsCGM%-I), together 
with the fourth clone &hsCGM3-I), was selected for closer analyses of the 
N-terminal domain exon regions. In a third approach, a number of other clones 
were isolated which showed very similar restriction patterns to hhsCGM3- 1, 
although these clones did hybridize with the Ikb Eco RI intron fragment from the 
NCA gene. Prior to closer analyses, an oligonucleotide (see Figure 2: oligo PSSC 1), 
based on sequence data from the 3’ end of the N-terminal domain of a cDNA 
clone which we recently isolated from a foetal liver library (results to be 
published), was used to probe these latter clones. This cDNA clone is identical to 
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Fig. 2. Nucleotide and predicted amino acid sequences of the N-terminal domain 
exons and flanking intron sequences of CEA-rela ed genes. Exon/intron borders are 
indicated by arrows. The simple repeated nucleotide sequences found upstream of 
the N-terminal domain exons are underlined. The boxed sequences for hsCGM1 and 
PSSG correspond to the oligonucleotides oligo CGMl and oligo PSBG 1, respectively. 
The underlined amino acid sequences represent potential glycosylation sites. 
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1 CBA 
Amino Acid Level 
hSCCN1 bSCGH2 PspG hsCGlI3 hsCGlt4 
I Nuclaotide Level I 
+ 
3 Comparison of the N-terminal domain exons of human CEA-like genes at the 
nut eotide and amino acid levels. The percentage similarity values were calculated 
after optimal alignment. The CEA sequence was derived from cDNA (8) and the 
NCA from genomic DNA sequences (9). 
one of the recently described PSBG cDNA clones (PLUG-D: 151. Oligo PSBG 1 
hybridized under stringent conditions with one of these genomic clones (APSBG-l), 
which was also selected for further analyses. 
In parallel, we also screened a human cosmid genomic library with various probes, 
and in one approach we isolated a clone (cosmid hsCGM4-11, using a 1.5kb EcoRI 
fragment probe from the 3’ non-translated region of the recently described NCA 
cDNA clone (11). This cosmid clone hybridized with oligo PS2G 1 under medium 
stringency conditions (SO’C in 6x SSPE), but not at higher stringency (6O’C in 6x 
SSPE), being, therefore, similar, but different to APSSG-1. 
Suitably sized restriction endonuclease fragments, which hybridized with the probe 
containing the N-terminal region of the NCA cDNA clone, pNCA1 (see above), were 
subcloned for each of these five genes. The sequencing strategies for these gene 
clones and their nucleotide and derived amino acid sequences are shown in Figures 
1 and 2. The exon/intron borders can be defined by the presence of donor/acceptor 
consensus sequences (281, as well as a sequence comparison to known data for the 
NCA gene (9) and its corresponding cDNA (11). Potential glycosylation positions are 
also shown, whereby some variations can be noted (Figure 2). The deduced amino 
acid sequences are compared with those for CEA and NCA in Figures 3 and 4. 
DNA/RNA hybridization analyses using specific probes for XhsCGMl-1, 2-l and 3-l 
were carried out to determine whether transcripts for these genes could be identi- 
fied. The probe used for XhsCGMl-1 was an oligonucleotide synthesized from the 6’ 
non-translated region, being complementary to a putative mRNA, which exhibits 
sequence differences to CEA and NCA (see Figure 2: oligo CGMl). For XhsCGM2-1, 
a Barn HI/Pst I genomic fragment, and for XhsCGh43-1, an Ssp I/Eco RI genomic 
fragment was used (see Figure l), both of which contain the N-terminal domain 
exons. These probes only hybridized with one genomic restriction endonuclease 
fragment under high stringency conditions (results not shown). No probes were 
tested for cosmid hsCGM4-1 and XPS8G-1, as their sequences are so closely related 
to XhsCGM3-1 (see Figure 31, that any related mRNA species should also have 
hybridized with the latter probe. None of the probes used could detect corres- 
ponding mRNAs under higher stringency conditions in any of the following human 
tumours which had been propagated in nude mice: carcinomas of the gall bladder 
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i sequences. 
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- 
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solid circles (18). Those not conserved in the- CEA family are marked with arrow 
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and pancreas, squamous carcinomas of the lung and cervix, two adenocarcinomas of 
the colon, a hepatoma and a bone metastasis of an oesophagus carcinoma. Also 
negative were the following primary tumours: four adenocarcinomas of the colon, 
an ovarian sarcoma, one serous and three mutinous ovarian carcinomas, one 
serous/mucinous ovarian carcinoma and leukocytes from a patient suffering from 
chronic myeloid leukaemia, as well as metastases from carcinomas of the stomach, 
colon and breast and normal colonic tissues. However, we were recently able to 
identify transcripts for PSBG and for hsCGM4 in a 31 week placenta using gene- 
specific oligonucleotide probes (results to be published). 
Discussion 
The data presented in Figures 2, 3 and 4 reveal that each of the five, newly 
isolated clones &hsCGMl - 1, lhsCGM2- 1 XhsCGM3- 1, XPSBG- 1 and cosmid 
hsCGM4-I), represents an individual member of the CEA gene family. At present, 
only one of these genes (PSBG), can be identified with respect to a known cDNA 
(15). The N-terminal domain exon for this gene, reveals only two nucleotide 
differences to the published cDNA data for PSBG (15) at positions 553 according to 
our numbering (G instead of C) and 559 (A instead of C) (Figure 2). These two 
changes both lead to exchanges in the deduced amino acid sequences of the 
APSBG-1 genomic clone: Glu for Gln, and Thr for Pro, respectively. We assume that 
this gene represents an allele of the published PSBG cDNA because of the 
otherwise identical coding sequences. For the other newly isolated genes, we have 
adopted a temporary nomenclature system, as recently proposed (3). until the gene 
products, when existent, have been identified. We have designated each gene 
numerically, according to its species (Homo sapiens = hs), as a CEA gene-family 
member (CGM). 
A comparison of the degrees of similarity for each gene with respect to the 
others, as well as to CEA and an NCA, is shown in Figure 3 at both the nucleo- 
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tide and amino acid levels. It is noticeable from these comparisons that the 
N-terminal regions of three genes and their products (CEA, NCA and hsCGM11, 
are very similar, and can, therefore, be grouped together. In a closer comparison 
(see Figure 41, hsCGM1 shows complete sequence similarity to CEA at the start of 
the exon, which explains the strong hybridization with the assumed CEA-specific 
oligonucleotide. Although not included in Figure 4, BGPI (13) can also be placed in 
this group. Three other genes (PSBG, hsCGM3 and 4) also show a very high 
sequence conservation amongst themselves, but their lower sequence similarity to 
the CEA group shows that they represent a second subgroup within the CEA gene 
family. PSBG-E (141, a second pregnancy-specific glycoprotein gene, can also be 
placed within this subgroup, as can SPl (16). The other gene (hsCGM21, reveals 
homology, but a lower sequence similarity to the CEA group, as well as to the 
PSBG group, indicating that it represents a separate entity or a third subgroup 
member within the CEA family. 
The seven sequences compared in Figure 4 reveal homology to the immunoglobulin 
superfamily through the conservation of 9 out of 13 critical amino acids (18). This 
evolutionary relationship becomes more obvious when the deduced secondary struc- 
tures are compared. In each case, a specific number of S-strands can be deduced, 
which are characteristic for the immunoglobulin-like fold. Williams (181, recently 
showed that the N-terminal domain of CEA reveals a close structural similarity to 
the variable domains of the immunoglobulins, whereas the CEA “half-repeats” are 
more similar to the constant domains. The extra B-strand (C’), which is a typical 
feature of immunoglobulin variable domains, appears to be present in the deduced 
secondary structures of the N-terminal regions for all seven members of the CEA 
family. In addition, the Cl/C” connecting loop, which represents a region of 
hypervariability in immunoglobulin variable domains, also reveals higher variability 
between the different subgroups of the CEA gene family. These structural 
similarities to members of the immunoglobulin superfamily indicate possible receptor 
or recognition functions for members of the CEA family. Specificity of function for 
each individual molecule could be determined by the hypervariable regions. It is 
noticeable that none of the seven human genes contain cysteine residues in their 
N-terminal domains. However, in all cases, the arginine and aspartic acid residues 
which build a salt bridge in the immunoglobulin variable domains (18). are 
conserved (Figure 4). Therefore, it may be assumed that this salt bridge is suffi- 
cient for stabilization of the two hypothetical B-sheets to form the immuno- 
globulin-like fold of this N-terminal domain in the CEA family. 
The high degree of sequence similarity between these CEA-related genes is not 
restricted to the exon regions. Indeed, a high sequence conservation is also 
apparent in the surrounding introns (Table 1). However, one interesting region of 
variability between NCA and the five newly isolated genes is apparent at a location 
Table 1: Comparison of the intron regions flanking the N-terminal domain exons 
%:: 
NCA 
NCA 
NCA 
i%i,“: 
hsCGM1 
hsCGM1 : PSBG 
k%E 
: hsCGM3 
: hsCGM4 
k6gg1;; : PSBG 
: hsCGM4 
hsCGM3 : PSBG 
hsCGM4 : PSBG 
80% 
82% 
80% 
82% 
94% 
K 
a The percentage similarity values were calculated after optimal 
only the regions covered by all gene 
ali nment. and 
fragments 
sequence has been published elsewhere (9). 
were considere . 3 The NCA 
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approximately 100 bp upstream from the start of the N-terminal exon. All six genes 
contain a region of simple-sequence DNA, [(dA-d%l, but of varying length (see 
Figure 2). This upstream region has already been described for the NCA gene 
(9,lO). In PSBG, hsCGM3, and 4 it is followed directly by a poly (dT-dG) sequence. 
In this latter subgroup a stable secondary structure in the form of a double-hair- 
pin, or cruciform could be formed. Such poly(dA-dC) . poly (dT-dG) sequences are 
highly repetitive in the human genome (29). Possible functions of these “TG- 
elements” have been discussed in the regulation of gene expression (30). or as 
recombination sites (3 1). 
With regard to the expression of these genes, the PSBG gene has been shown, 
through Northern blot analyses (own unpublished results), as well as through 
isolation of corresponding cDNA clones to be transcribed in the placenta (151, and 
in foetal liver (own unpublished results). PSBG represents a member of a hetero- 
genous group of pregnancy-specific glycoproteins (32,331. At least three of these 
immunologically crossreacting glycoproteins were recently isolated from human 
placenta, with apparent molecular masses of 72, 64 and 54 kDa (15). The close 
sequence similarity of the PSBG gene subgroup (PS’BG, hsCGM3 and 4) presented 
here (compare also PZXG-E: 14 and SPl: 16), indicates that these pregnancy 
proteins are encoded by distinct, but highly conserved genes. Investigations to 
determine this are underway. In order to analyse the potential of these gene 
products as tumour markers, as well as an attempt to identify potential transcripts 
for the non-identified genes, we have begun to screen different tumours in 
Northern analyses. So far, none of the tumours investigated revealed expression of 
any of these newly-isolated, CEA-related genes but as mentioned, expression of 
PSBG and hsCGM4 has been found in the placenta. This indicates a high tissue- 
specificity of expression. At present, it cannot be ruled out that hsCGM1, 2 and 3 
are pseudogenes. 
If we compare our results with published data (4-161, and assuming that the N- 
terminal domain occurs only once per gene, then a total of eleven genes have so 
far been identified which belong to t,he CEA gene family. These are; CEA (4-81, 
NCA (g-121, BGPl (131, hsCGM1, hsCGM6 (a clone recently isolated in our 
laboratory from a cDNA library 
leukaemia patient: results to be 
hsCGM3, hsCGM4 and hsCGM2. 
costructed from the spleen of a chronic myeloid 
published), PS8G (cf. 14,151, PSSG-E (141, SPl (161, 
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